CY1108413T1 - Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων - Google Patents
Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειωνInfo
- Publication number
- CY1108413T1 CY1108413T1 CY20081101136T CY081101136T CY1108413T1 CY 1108413 T1 CY1108413 T1 CY 1108413T1 CY 20081101136 T CY20081101136 T CY 20081101136T CY 081101136 T CY081101136 T CY 081101136T CY 1108413 T1 CY1108413 T1 CY 1108413T1
- Authority
- CY
- Cyprus
- Prior art keywords
- discipates
- treatment
- pharmaceutical composition
- composition including
- including ethanol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Massaging Devices (AREA)
Abstract
Το προϊόν σύμφωνα με την εφεύρεση συνίσταται σε ένα ενέσιμο φαρμακευτικό σκεύασμα περιλαμβάνον τουλάχιστον μία ένωση η οποία δίδει ένα παχύρρευστο σκεύασμα, αιθανόλη και τουλάχιστον μία ένωση η οποία καθιστά το εν λόγω σκεύασμα αδιαφανές στις ακτίνες Χ κατά τρόπον ώστε να ελέγχεται η χορήγηση και η δράση του. Εφαρμόζεται ειδικά στην αγωγή των δισκοπαθειών αλλά επίσης και στις παρεμβατικές διαδικασίες που έχουν αποδείξει την αποτελεσματικότητα της καθαρής αιθανόλης: αγωγή των ηπατοκυτταρικων όγκων ή ακόμη των οστεοειδών οστεωματων, των κύστεων των νεφρών και των αρτηριοφλενικών αγγειωμάτων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0205819A FR2839450B1 (fr) | 2002-05-07 | 2002-05-07 | Preparation medicamenteuse notamment pour le traitement des hernies discales |
EP03752788A EP1503803B1 (fr) | 2002-05-07 | 2003-05-07 | Composition pharmaceutique injectable comprenant de l'éthanol pour le traitement des hernies discales |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108413T1 true CY1108413T1 (el) | 2014-02-12 |
Family
ID=29286406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101136T CY1108413T1 (el) | 2002-05-07 | 2008-10-14 | Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων |
Country Status (15)
Country | Link |
---|---|
US (3) | US20070116647A1 (el) |
EP (1) | EP1503803B1 (el) |
CN (1) | CN100402020C (el) |
AT (1) | ATE402719T1 (el) |
AU (1) | AU2003262617A1 (el) |
CA (1) | CA2498976C (el) |
CY (1) | CY1108413T1 (el) |
DE (1) | DE60322530D1 (el) |
DK (1) | DK1503803T3 (el) |
ES (1) | ES2309334T3 (el) |
FR (1) | FR2839450B1 (el) |
HK (1) | HK1081849A1 (el) |
PT (1) | PT1503803E (el) |
SI (1) | SI1503803T1 (el) |
WO (1) | WO2003097108A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2839450B1 (fr) * | 2002-05-07 | 2006-04-07 | Aboville Marc D | Preparation medicamenteuse notamment pour le traitement des hernies discales |
FR2891461B1 (fr) * | 2005-09-30 | 2010-09-03 | Jacques Theron | Preparation medicamenteuse visqueuse injectable comprenant de l'ethanol et un compose liposoluble opaque aux rayons x. |
EP3679140B1 (en) | 2017-09-08 | 2022-11-16 | MiNA Therapeutics Limited | Stabilized cebpa sarna compositions and methods of use |
TW201920669A (zh) | 2017-09-08 | 2019-06-01 | 英商美納治療公司 | HNF4a saRNA組成物和使用方法 |
EP4017539A1 (en) | 2019-08-19 | 2022-06-29 | MiNA Therapeutics Limited | Oligonucleotide conjugate compositions and methods of use |
CN117222405A (zh) * | 2021-03-04 | 2023-12-12 | 苏州医本生命科技有限公司 | 一种含乙醇的药物组合物及其用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2162028A (en) * | 1938-06-25 | 1939-06-13 | Pittsburgh Plate Glass Co | Cellulose ether coating composition |
US2903396A (en) * | 1957-05-08 | 1959-09-08 | Ciba Pharm Prod Inc | Therapeutic compositions and method for treating parkinsonism |
EP0304403A3 (de) * | 1987-08-21 | 1990-12-12 | Ciba-Geigy Ag | Kunststoffzusammensetzung mit Supraleitern |
JPH02157029A (ja) * | 1988-12-09 | 1990-06-15 | Dainippon Pharmaceut Co Ltd | アニオン系界面活性剤含有組成物の安定化 |
US5830178A (en) * | 1996-10-11 | 1998-11-03 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide |
US6476070B2 (en) * | 1997-09-11 | 2002-11-05 | Provasis Therapeutics Inc. | Compositions useful for remodeling body spaces |
US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
US6150022A (en) * | 1998-12-07 | 2000-11-21 | Flex Products, Inc. | Bright metal flake based pigments |
EP1180051A4 (en) * | 1999-05-21 | 2004-06-30 | Micro Therapeutics Inc | METHODS FOR EMBOLIZING BLOOD VESSELS WITH AN EMBOLIZING CONNECTION |
JP5148030B2 (ja) * | 1999-05-21 | 2013-02-20 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 新規の高粘度塞栓形成組成物 |
US6355058B1 (en) * | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
US20020115904A1 (en) * | 2001-02-21 | 2002-08-22 | Brooke Ren | Magnetically controllable embolic materials |
FR2839450B1 (fr) * | 2002-05-07 | 2006-04-07 | Aboville Marc D | Preparation medicamenteuse notamment pour le traitement des hernies discales |
-
2002
- 2002-05-07 FR FR0205819A patent/FR2839450B1/fr not_active Expired - Lifetime
-
2003
- 2003-05-07 ES ES03752788T patent/ES2309334T3/es not_active Expired - Lifetime
- 2003-05-07 DE DE60322530T patent/DE60322530D1/de not_active Expired - Lifetime
- 2003-05-07 AU AU2003262617A patent/AU2003262617A1/en not_active Abandoned
- 2003-05-07 EP EP03752788A patent/EP1503803B1/fr not_active Expired - Lifetime
- 2003-05-07 SI SI200331368T patent/SI1503803T1/sl unknown
- 2003-05-07 US US10/513,592 patent/US20070116647A1/en not_active Abandoned
- 2003-05-07 PT PT03752788T patent/PT1503803E/pt unknown
- 2003-05-07 WO PCT/FR2003/001412 patent/WO2003097108A1/fr active IP Right Grant
- 2003-05-07 CA CA2498976A patent/CA2498976C/fr not_active Expired - Fee Related
- 2003-05-07 AT AT03752788T patent/ATE402719T1/de active
- 2003-05-07 DK DK03752788T patent/DK1503803T3/da active
- 2003-05-07 CN CNB038129361A patent/CN100402020C/zh not_active Expired - Fee Related
-
2006
- 2006-02-17 HK HK06102101.6A patent/HK1081849A1/xx not_active IP Right Cessation
-
2008
- 2008-10-14 CY CY20081101136T patent/CY1108413T1/el unknown
-
2010
- 2010-08-27 US US12/870,258 patent/US8153696B2/en not_active Expired - Fee Related
-
2012
- 2012-11-19 US US13/681,175 patent/US20130143970A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1665546A (zh) | 2005-09-07 |
US20130143970A1 (en) | 2013-06-06 |
FR2839450A1 (fr) | 2003-11-14 |
WO2003097108A1 (fr) | 2003-11-27 |
CA2498976A1 (fr) | 2003-11-27 |
DK1503803T3 (da) | 2008-11-10 |
EP1503803A1 (fr) | 2005-02-09 |
CN100402020C (zh) | 2008-07-16 |
EP1503803B1 (fr) | 2008-07-30 |
FR2839450B1 (fr) | 2006-04-07 |
ATE402719T1 (de) | 2008-08-15 |
CA2498976C (fr) | 2011-09-06 |
US20070116647A1 (en) | 2007-05-24 |
HK1081849A1 (en) | 2006-05-26 |
DE60322530D1 (de) | 2008-09-11 |
ES2309334T3 (es) | 2008-12-16 |
PT1503803E (pt) | 2008-10-16 |
AU2003262617A1 (en) | 2003-12-02 |
US20100329991A1 (en) | 2010-12-30 |
US8153696B2 (en) | 2012-04-10 |
SI1503803T1 (sl) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0015188A (pt) | Composições farmacêuticas | |
CY1107294T1 (el) | Τοπικη συνθεση η οποια περιεχει τουλαχιστον μια βιταμινη d ή ενα αναλογο της βιταμινης d και τουλαχιστον ενα κορτικοστεροειδες | |
NO20053150D0 (no) | System for administrasjon av medisin. | |
EP2409569A3 (en) | Method for administering GLP-1 molecules | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
CY1106386T1 (el) | Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης | |
CY1105120T1 (el) | Η αντιμετωπιση αναπνευστικων νοσων | |
DE602004027936D1 (de) | Tocopherolmodifizierte therapeutische arzneimittelverbindung | |
CY1109661T1 (el) | 5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης | |
NO20053224D0 (no) | Patient controlled drug administration device. | |
CY1108413T1 (el) | Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων | |
BR0306870A (pt) | Composição farmacêutica oral, e, método para preparar a mesma | |
ATE357928T1 (de) | Pharmazeutische zusammensetzung für thrombinpeptidderivaten | |
TR200100895T2 (tr) | Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı | |
ATE326968T1 (de) | Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer | |
WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
EA200501697A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
WO2005058824A3 (en) | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b | |
CL2004001421A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor. | |
MA27418A1 (fr) | Ensemble de distribution de medicament. | |
EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
MA27689A1 (fr) | Forme galenique orale pour la liberation controlee de medicament | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение |